secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2023-12-12T23:59:59+00:00
Accession:  0001641489-23-000082
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics regains Nasdaq minimum bid compliance after reverse stock split
--------------------------------------------------------------------------------

- Nasdaq notified vTv on Dec 11, 2023 that it regained $1.00 minimum bid price compliance.
- Company had received deficiency letter on Dec 22, 2022; extended deadline to Dec 18, 2023.
- Effected a reverse stock split on Nov 20, 2023 to meet the bid price requirement.
- Listing of common stock on Nasdaq Capital Market will continue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000082/0001641489-23-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000082/vtvt-20231211.htm
  HTML page:      https://secwatch.observer/filing/0001641489-23-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer